期刊
JOURNAL OF EXPERIMENTAL MEDICINE
卷 216, 期 3, 页码 517-526出版社
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20181169
关键词
-
资金
- Deutsche Forschungsgemeinschaft [SFB 654, SFB 685]
- German Federal Ministry of Education and Research [01GI0925]
- European Research Council [AdG 339842]
Efficient T cell responses require the firm adhesion of T cells to their targets, e.g., virus-infected cells, which depends on T cell receptor (TCR)-mediated activation of beta(2)-integrins. G alpha(s)-coupled receptor agonists are known to have immunosuppressive effects, but their impact on TCR-mediated integrin activation is unknown. Using multimers of peptide major histocompatibility complex molecules (pMHC) and of ICAM-1-the ligand of beta(2)-integrins-we show that the G alpha(s)-coupled receptor agonists isoproterenol, epinephrine, norepinephrine, prostaglandin (PG) E-2, PGD(2), and adenosine strongly inhibit integrin activation on human CMV- and EBV-specific CD8(+) T cells in a dose-dependent manner. In contrast, sleep, a natural condition of low levels of G alpha(s)-coupled receptor agonists, up-regulates integrin activation compared with nocturnal wakefulness, a mechanism possibly underlying some of the immune-supportive effects of sleep. The findings are also relevant for several pathologies associated with increased levels of G alpha(s)-coupled receptor agonists (e.g., tumor growth, malaria, hypoxia, stress, and sleep disturbances).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据